CIK 0001339005 · <br>Emerging growth company
FEMASYS INC
Sign in to watch- Ticker
- FEMY
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 113713499
- Phone
- 770-500-3910
- Business address
- 3950 JOHNS CREEK COURT, SUITE 100, SUWANEE, GA, 30024
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-03 | Elefant Dov Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +204,700 | 204,700 | ||
| 2023-07-03 | Currie Daniel Scott Senior VP, Operations | Grant or award · Stock Option (Right to Buy) | +84,600 | 84,600 | ||
| 2023-07-03 | Currie Daniel Scott Senior VP, Operations | Grant or award · Stock Option (Right to Buy) | +124,800 | 124,800 | ||
| 2023-07-03 | Lee-Sepsick Kathy Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +270,400 | 270,400 | ||
| 2023-07-03 | Lee-Sepsick Kathy Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +271,900 | 271,900 | ||
| 2023-06-21 | Morrissey Anne Director | Grant or award · Stock Option (Right to Buy) | +8,500 | 8,500 | ||
| 2023-06-21 | Larsen Charles Director | Grant or award · Stock Option (Right to Buy) | +8,500 | 8,500 | ||
| 2023-06-21 | Perrow Wendy Director | Grant or award · Stock Option (Right to Buy) | +8,500 | 8,500 | ||
| 2023-06-21 | Uzialko Edward R Director | Grant or award · Stock Option (Right to Buy) | +8,500 | 8,500 | ||
| 2023-06-14 | Milnes Alistair Director | Grant or award · Stock Option (Right to Buy) | +17,000 | 17,000 | ||
| 2023-06-14 | Kendall Keith J Director | Grant or award · Stock Option (Right to Buy) | +17,000 | 17,000 | ||
| 2022-10-10 | Thomas Christine E SVP, Regulatory & Clinical | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2022-06-08 | Dyett John Director | Grant or award · Stock Option (Right to Buy) | +8,500 | 8,500 | ||
| 2022-06-08 | Perrow Wendy Director | Grant or award · Stock Option (Right to Buy) | +8,500 | 25,500 | ||
| 2022-06-08 | Morrissey Anne Director | Grant or award · Stock Option (Right to Buy) | +8,500 | 8,500 | ||
| 2022-06-08 | Larsen Charles Director | Grant or award · Stock Option (Right to Buy) | +8,500 | 8,500 | ||
| 2022-06-08 | Adams John Q JR Director | Grant or award · Stock Option (Right to Buy) | +8,500 | 8,500 | ||
| 2022-06-08 | Uzialko Edward R Director | Grant or award · Stock Option (Right to Buy) | +8,500 | 8,500 | ||
| 2022-02-28 | Elefant Dov Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2022-01-25 | Currie Daniel Scott Senior VP, Operations | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 |
Page 5 of 7 · 127 trades